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ABSTRACT 
DACH1 is the human homologue of the Drosophila dachshund gene, which is 
involved in the development of the eye, nervous system, and limbs in the fly. Here, we 
systematically investigate DACH1 expression pattern during human neurodevelopment, 
from 5 to 21 post-conceptional weeks. By immunodetection analysis, we found that DACH1 
is highly expressed in the proliferating neuroprogenitors of the developing cortical ventricular 
and subventricular regions, while it is absent in the more differentiated cortical plate. Single-
cell global transcriptional analysis revealed that DACH1 is specifically enriched in 
neuroepithelial and ventricular radial glia cells of the developing human neocortex. 
Moreover, we describe a previously unreported DACH1 expression in the human striatum, 
in particular in the striatal medium spiny projection neurons. This finding qualifies DACH1 
as a new striatal projection neuron marker, together with PPP1R1B, BCL11B, and EBF1. 
We eventually compared DACH1 expression profile in human and mouse forebrain, where 
we observed spatio-temporal similarities in its expression pattern thus providing a precise 
developmental description of DACH1 in the two mammalian species.  
 
 
Keywords: DACH1, human neocortex, human striatum, medium spiny neurons, 
neuroepithelial cells.  
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INTRODUCTION 
During human development, a complex interplay of dynamic processes operates 
within a genetically organized context in the forebrain primordium, which ultimately defines 
area-specific molecular expression domains underlying brain functions (Monuki ES and CA 
Walsh 2001; Rakic P 2009; Lui JH et al. 2011; Silbereis JC et al. 2016). Recent studies have 
described the human forebrain transcriptome organization, delineating the spatio-temporal 
regulation of gene expression that specifies early neocortical and striatal progenitors and 
their progeny (Kang HJ et al. 2011; Miller JA et al. 2014; Onorati M et al. 2014). These efforts 
produced a plethora of differentially expressed genes (DEGs) and gene modules that 
distinguish the developing human striatum from the neocortex. In our previous study, we 
were able to define a precise spatio-temporal map of developmental factors involved in 
striatal and neocortical neuron determination and differentiation in humans. Among these 
relevant genes, we identified Dachshund family transcription factor 1 (DACH1) as a 
neocortical enriched DEG and bimodal expressed gene (Onorati M et al. 2014). Then, by 
looking at the Human Brain Transcriptome Atlas we found that DACH1, later on, decreases 
its expression in the neocortex but shows a stable expression in the striatum until adulthood 
(Kang HJ et al. 2011). Based on these expression data, and since no data were available in 
human brain on the protein expression level, we carried out a detailed expression analysis 
of DACH1 during human cortical and striatal development to characterize its cell type 
specificity in these two brain regions. 
The DACH1 homologue in Drosophila, dachshund, plays a pivotal role in the 
differentiation of the eye imaginal disc, in leg morphogenesis and in controlling neural 
differentiation in the mushroom bodies, a neural structure required for learning and memory 
in flies. Drosophila dachshund mutant flies lack eyes, have truncated limbs and exhibit brain 
abnormalities (Mardon G et al. 1994; Kurusu M et al. 2000; Martini SR et al. 2000). 
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In mouse, Dach1 encodes for a transcription factor expressed during development in 
restricted areas of the central nervous system (CNS), eye, neural crests and limb buds 
(Mardon G et al. 1994; Hammond KL et al. 1998; Caubit X et al. 1999; Davis RJ et al. 1999; 
Kozmik Z et al. 1999). Mouse Dach1-null homozygotes survive pregnancy but die within 24 
hours after birth (Davis RJ et al. 2001; Backman M et al. 2003). In the developing 
telencephalon, Dach1 mRNA shows strong expression in the neural stem/progenitor cells 
of the ventricular and subventricular zone (VZ and SVZ, respectively) of the neocortex, in 
medial and lateral ganglionic eminences (MGE and LGE, respectively), and hippocampus 
(Machon O et al. 2002).   
Recently, DACH1 expression was detected in early fetal human neocortex by PCR 
(Straccia M et al. 2015). Moreover, DACH1 was reported to mark in vitro-derived rosette-
like neuroepithelial stem cells (Elkabetz Y et al. 2008) and to act as a tumor suppressor 
gene (Chu Q et al. 2014). In particular, its expression is altered in several cancers, including 
glioblastoma (Watanabe A et al. 2011). 
This work describes the dynamic expression profile of DACH1 in the human 
neocortex and striatum of samples aged 5 to 21 post-conceptional weeks (pcw). We found 
that DACH1 is expressed in the VZ/SVZ regions of the developing human cerebral cortex at 
all the stages analysed. Furthermore, by analysing single-cell RNA-seq dataset on the 
human developing neocortex (Onorati M et al. 2016), we identified DACH1 as a specific 
marker of neuroepithelial and ventricular radial glial cells (vRGCs). Starting from 10 pcw, we 
found a DACH1 protein expression in the human striatum that was not previously reported, 
to the best of our knowledge, suggesting a different role for DACH1 in two distinct regions 
and times, and qualifying DACH1 as a marker of striatal medium spiny projection neurons 
(MSNs). 
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Materials and Methods 
Human Tissue  
De-identified post-mortem human brain specimens were obtained from patients that 
requested pregnancy terminations and autopsy diagnostic procedures. All procedures were 
approved by the research ethical committees and research services division of the 
University of Cambridge and Addenbrooke's Hospital in Cambridge (protocol 96/85, 
approved by Health Research Authority, Committee East of England - Cambridge Central 
in 1996 and with subsequent amendments, with the latest approved November 2017) and 
by the Ethics Committee of San Paolo Hospital, Milano (protocol 11186, approved on July 
19, 2013. The ethics were fully reviewed and approved in the UK, in accordance with the 
Human Tissue Act 2006. Both documents were submitted to the Ethics Committee of the 
University of Milano and ethical approval was obtained on March 27, 2013. Appropriate 
informed consent was obtained and all available non-identifying information was recorded 
for each specimen. Tissue was handled in accordance with ethical guidelines and 
regulations for the research use of human brain tissue set forth by the National Institute of 
Health (NIH) (http://bioethics.od.nih.gov/humantissue.html) and the World Medical 
Association Declaration of Helsinki 
(http://www.wma.net/en/30publications/10policies/b3/index.html). 
 
Definition of human developmental periods 
We used post-conceptional weeks (pcw) to indicate the developmental age of the human 
embryo and fetus (also termed post-fertilization or post-ovulatory age). For embryonic 
stages (up to 8 pcw) we based on multiple physical features (e.g. somites). For fetal stages 
we calculated the age by subtracting 2 weeks to the gestational age (calculated on the 
mother’s last menstruation), crown to rump length (CRL), anatomical landmarks, and by 
visual inspection, as previously described (Onorati M et al. 2014). 
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According to (Kang HJ et al. 2011), we used the following developmental periods to describe 
the samples employed in this study: 
Embryonic development, up to 8 pcw 
Early fetal development, 8 pcw to 13 pcw 
Early mid-fetal development, 13 pcw to 19 pcw 
Late mid-fetal development, 19 pcw to 24 pcw 
  
Human tissue collection  
This study was conducted with post-mortem human brain specimens from tissues collected 
at the John van Geest Centre for Brain Repair, University of Cambridge, Cambridge, UK. 
Additional specimens were procured from the San Paolo Hospital, Milan, Italy. Details of the 
specimens analyzed are provided in the Supplementary Table 1. 
 
Brain sampling for immunostaining 
As previously described (Onorati M et al. 2014), specimens were chilled on ice during 
dissection and placed onto a chilled plate on ice. The entire brain (when possible) was 
removed and fixed for 2-4 days in 4% formaldehyde (FA) at 4°C. Samples were then 
cryoprotected in 30% sucrose (in PBS), embedded in tissue-tek, stored at -80°C and then 
cryosectioned (12-30 µm).  
  
Immunofluorescence 
Brain sections were rehydrated for 10 min with PBS, then permeabilized with 0.5% Triton X-
100, and blocked with 5% FBS for 1 h at room temperature. Brain sections were incubated 
overnight at 4°C with primary antibodies, listed in Supplementary Table 2. Alexa 488 or 568-
conjugated secondary antibodies (Molecular Probes) were diluted 1:500 and mixed with 
DAPI (Molecular Probes, Invitrogen) to counterstain the nuclei. Sections were mounted with 
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fluorescent mounting medium (Dako). Images were acquired with Leica DMI 6000B and 
DM4000B (Leica Microsystem) microscopes, analysed with LAS-AF imaging software and 
then processed with Adobe Photoshop. Confocal images were acquired with a Leica TCS 
SP2 microscope (Leica Microsystem) and then processed with Adobe Photoshop. 
 
Cell counting 
The positivity and specificity of each primary and secondary antibody used in this work was 
evaluated against a negative control intended as both non-expressing human brain regions 
(e.g. spinal cord) and slices stained exclusively with secondary antibody. The majority of 
antibodies used were selected from literature and previously tested on mouse and human 
brain. Automatic cell counting performed using Cell Profiler. Statistical tests were performed 
with PRISM software (GraphPad, ver 6). All results are expressed as mean +/- s.d.  
  
In situ hybridization  
In situ hybridization experiments were performed as previously described (Onorati M et al. 
2014), on 15-25 µm thick brain cryosections upon post fixation in 4% FA. Sections were 
then washed 3 times in PBS and incubated with 0.5 mg/mL of proteinase K in 100 mM Tris-
HCl (pH 8) and 50 mM EDTA for 10 min at 30°C and then 15 min in 4% FA. Slices were 
washed 3 times in PBS before receiving H2O washes. Sections were incubated in 
Triethanolamine 0.1 M (pH 8) for 5 min, then 400 µL of acetic anhydride was added 2 times 
for 5 min each. Finally, sections were rinsed in H2O for 2 min and air-dried. Hybridization 
was performed overnight at 60°C, incubating either sense or antisense P33 labelled 
riboprobes at a concentration of 6 X 106 counts per minute (cpm/slide). The following day, 
sections were rinsed in SSC 5X for 5 min then washed in formamide 50% SSC 2X for 30 
min at 60°C, before receiving Ribonuclease-A (Roche) treatment (20 mg/mL in 0.5M NaCl, 
10 mM Tris-HCl pH 8, and 5 mM EDTA 30 min at 37°C). Sections were further washed in 
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formamide 50% SSC 2X for 30 min at 60°C and then rinsed 2 times in SSC 2X. Slides were 
dried by using ethanol series. NTB (Kodak) emulsion was applied in dark room, according 
to manufacturer’s instructions. Sections were developed after 1 week and mounted with 
DPX (BDH) mounting solution. Human DACH1 probe was cloned by PCR from nucleotide 
1545 to nucleotide 2450 according to Genbank information (NM_080759.5). Mouse Dach1 
probe was cloned by PCR from nucleotide 1668 to nucleotide 2606, according to Genbank 
information (NM_007826.3). Bright field imaging was performed by Olympus BX52 and 
Leica Aperio AT2 – digital scanner.  
 
Primers used for making human DACH1 probe: 
Forward: GTCGGACTGGAACTTCCTTTTATGATG 
Reverse: GGGTCAGAGAGTCATTTAAGACCCTG 
Probe length 904 from Genbank NM_080759.5 
 
Primers used for making mouse Dach1 probe: 
Forward: GTTAGCCATCCTCTCAACCATCTGC 
Reverse: TCATTTAAGACCCGGAGACTGTCCG 
(Allen brain atlas probe). 
 
Single-cell RNA-seq data analysis 
Single-cell RNA-seq datasets of the developing neocortex were retrieved from an earlier 
study (Onorati M et al., 2016). Prenatal neocortical cells from 5 to 20 pcw were analyzed. 
Only cells that passed quality control according to Onorati M et al. (2016) were used. Cell 
clustering was conducted by supervised hierarchical clustering with a solicited list of marker 
genes identifying major cell types in the neocortex. The R program, Monocle, was used to 
reconstruct cell lineage and pseudotime for the cells in the dataset using default parameters 
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(Trapnell C et al. 2014). Log2 transformed RPKM values were used as input. Violin plots 
were generated using R package ggplot2 and gene RPKM values were used. The analysis 
pipeline to identify genes correlated and anti-correlated with DACH1 was performed using 
the package described by (Lun AT et al. 2016) on log2 RPKM values. Briefly, genes that had 
Spearman’s rho > 0 and a FDR < 0.05 with DACH1 were considered as correlated with 
DACH1, whereas genes with a Spearman’s rho < 0 and a FDR < 0.05 with DACH1 were 
considered as anti-correlated with DACH1.  
 
Hub gene identification 
Identification of hub genes was performed using the TopGO function of the Functional Gene 
Networks (FGNet), an R/Bioconductor package (Aibar S et al. 2015) on genes that highly 
correlate with DACH1. Node size was set to 20 and the p-value threshold < 0.05. The gene 
universe was defined as all expressed genes that had 25 accumulative gene counts in all 
samples and RPKM > 1 in at least 5 of the samples and only GO “Biological processes” 
were considered. Filter threshold for metagroups was set to be > 40.  
 
RESULTS 
DACH1 shows a peculiar pattern in the human VZ and SVZ 
In order to define the regional expression of DACH1 in the cerebral cortex during 
human fetal development, we carried out an immunofluorescence analysis, first focusing our 
attention to a 10 pcw specimen, corresponding to early fetal development. This period is 
characterized by the consolidation of the cortical plate (CP), while the developing striatum 
starts to be separated into the caudate and putamen by the internal capsule. By 
immunostaining on whole human coronal brain sections, we found that DACH1 clearly 
showed a rostral to caudal expression pattern, with a very weak expression rostrally (Fig. 
1A-C). At the level of the paracentral section, DACH1 expression was present in the VZ of 
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the pallium, with a sharp edge at the level of the pallial-subpallial boundary (PSB) (Fig.1B, 
arrow). We performed a co-labeling of DACH1 with KI67, a static marker of proliferative 
activity (Gerdes J et al. 1983). DACH1 was expressed in the proliferative regions (VZ, SVZ) 
of the developing human neocortex (Fig.1A-C’). Double immunofluorescence analysis at 
caudal levels clearly showed that many cells in the VZ/SVZ regions were proliferative as 
assessed by KI67 co-expression (Fig. 1D-F). In particular, we found that 48 ± 12.2 % of total 
cells was DACH1+/KI67+ (Supplementary Table 3A). Finally, we compared DACH1 
expression with that of BCL11B (also known as CTIP2), a transcription factor involved in the 
development of layer 5 projection neurons (Leid M et al. 2004; Arlotta P et al. 2005). DACH1 
and BCL11B showed a mutually exclusive expression pattern, with DACH1 expressed 
mainly in the VZ/SVZ regions (Fig. 1G-K), and BCL11B mostly confined to the intermediate 
zone (IZ) / CP (Fig. 1G-K). We found only few cells co-expressing BCL11B and DACH1 (Fig. 
1K, arrow).  
 
DACH1 is expressed in the VZ/SVZ regions during embryonic and early fetal 
development along the medio-lateral axis 
To determine whether DACH1 was also present at earlier stages of human 
development, we performed an immunodetection study on a 7 pcw + 2d embryonic 
specimen (Fig. 2A-C). We found that DACH1 was co-expressed in the VZ together with 
SOX3 (Fig. 2A), PAX6 (Fig. 2B), well-known neural progenitor markers, and KI67 (Fig. 2C). 
This pattern of expression was then conserved at 10 pcw (Fig. 2D-F), where 77 ± 4.1 % of 
the cells was DACH1/SOX3 double-positive and 76 ± 4.0 % was DACH1/PAX6 double-
positive in the VZ/SVZ regions (Supplementary Table 3A). 
Next, we decided to investigate the medio-lateral expression pattern of DACH1 (Fig. 
2G,H), using a (9 pcw + 5 d) human fetal brain specimen in order to substantiate the 
expression analysis described above. We decided to focus our attention on the rostro-
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caudal levels analyzed in Figure 1 B,C where DACH1 expression was stronger. DACH1 
signal was localized with similar levels along the medial-lateral axis (Fig. 2G, and boxes 1-
4) in the VZ/SVZ regions, with no detectable signal in the CP. This pattern was conserved 
also in more caudal sections (Fig. 2H, and boxes 1-2). 
Finally, we analyzed DACH1 expression at 21 pcw (Supplementary Fig. 1A-D). In this 
late mid-fetal specimen, DACH1 was localized in the cortical VZ, with fading expression in 
SVZ, IZ, subplate (SP), and CP (Supplementary Fig. 1A,A’). Supplementary Figure 1A’’ 
shows the reduced DACH1 expression moving from the VZ to the SVZ.  
We then performed in situ hybridization (ISH) for DACH1 on adjacent sections to 
study its weak expression in the CP (Supplementary Fig. 1B,B’). By using this more sensitive 
assay, we could detect the DACH1 transcript signal in the CP, although at low level. In the 
VZ/SVZ regions, also at this stage DACH1 co-localized with SOX3 (Supplementary Fig. 1C) 
and the RGC marker TFAP2C (also known as AP2γ) (Supplementary Fig. 1D). 
 
Single-cell transcriptional profiling reveals DACH1 expression in neuroepithelial cells 
and vRGCs. 
To fully comprehend DACH1 expression in time, and to pinpoint cell populations 
expressing this gene with a greater resolution, we decided to extend our investigation by 
analyzing the recently published single-cell RNA-seq dataset on the developing human 
neocortex (Onorati M et al. 2016). Towards this aim, we initially clustered cells deriving from 
fetal samples from early embryonic to late mid-fetal periods (5 to 20 pcw) to verify the cellular 
identities arising in the developing neocortex. Supplementary Figure 2A shows the cellular 
subtypes identified by marker-driven clustering, where we could identify DACH1 as one of 
the players characterizing neuroepithelial and vRGCs.  
In particular, by pseudotemporal ordering of cells we observed that DACH1 has a 
significantly higher (p-adj. < 0.001) expression between 5 and 6 pcw compared to 16-20 
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pcw (Fig. 3A). Furthermore, DACH1 was specifically enriched (p-adj. < 0.001) in the cluster 
represented by neuroepithelial cells and vRGCs (Fig. 3B). The other cell populations of 
neural progenitors and neurons did not enrich for DACH1 (Fig. 3B). We then defined genes 
that have maximum correlation and anti-correlation pattern with DACH1 (Fig. 3C). We 
identified 61 genes that have a high correlation (FDR < 0.05, Supplementary Table 4) with 
DACH1, including the Cyclin Dependent Kinase (CDK1), the Centromere Protein E 
(CENPE), and the neuroprogenitor determinant ID4 (Fig. 3C). On the other hand, DACH1 
was anti-correlated with synaptic and receptor genes, such as the glutamate ionotropic 
receptor GRIA4 and the plexin receptor PLXNA4 (Fig. 3C). Within the set of correlated 
genes, DACH1 emerged as a hub gene (Fig. 3D) in functional annotations like “Nuclear DNA 
replication”, “Regulation of DNA biosynthetic process”, “Neuronal stem cell population 
maintenance”, and “Cell proliferation in forebrain” (p < 0.05, Supplementary Table 5). This 
picture is in line with the nature of dividing neuroepithelial cells and vRGCs and with 
immunodetection results that showed DACH1 co-expressed with PAX6 and KI67 in the VZ 
(Fig. 1D-F).  
 
DACH1 is expressed in the human fetal striatum 
We further studied DACH1 expression pattern during human brain development by 
taking into account the previously observed striatal expression (see Fig. 1B). First, we 
compared DACH1 profile during early fetal development with FOXP1, FOXP2, and BCL11B, 
three transcription factors highly expressed during human striatum development and in 
particular in MSNs (Onorati M et al. 2014) (Supplementary Fig. 3A-L). We found that DACH1 
was similarly expressed in the developing striatum from 8 to 10 pcw (Supplementary Fig. 
3A-C).  
Next, we performed co-stainings with a panel of striatal markers at 10 pcw (Fig. 4A). 
Strong DACH1 signal was present in the striatum at this stage, co-expressed with EBF1 
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(Fig. 4B-C’), ISL1 (Fig. 4D,D’), and BCL11B (Fig. 4E,E’). We investigated co-expression 
pattern with the different striatal markers at 10 pcw, where DACH1 resulted expressed in 
30.6 ± 7.6 % of total striatal cells (Fig. 4F). We quantified the number double-positive cells, 
finding 24 ± 7 % of cells co-expressing DACH1 and EBF1, 25 ± 6.6 % DACH1 and ISL1, 
and 43.1 ± 11.1 % DACH1 and BCL11B. When the number of double-positive cells was 
normalized to the total number of DACH1+ cells, we found that 77.8 ± 4.6 % of DACH1 
expressed EBF1, 78.9 ± 6.7 % expressed ISL1, and 100% expressed BCL11B (Fig. 4F and 
Supplementary Table 3B). DACH1 resulted also co-expressed with PPP1R1B (also known 
as DARPP-32), a mature striatal MSN marker (Kang HJ et al. 2011; Onorati M et al. 2014) 
(Fig. 4G).    
We also evaluated DACH1 signal in the 21 pcw human striatum. DACH1 was 
localized in the mantle region together with EBF1 (Supplementary Fig. 4A,A’), ISL1 
(Supplementary Fig. 4B,B’), BCL11B (Supplementary Fig. 4C,C’), and PPP1R1B 
(Supplementary Fig. 4D,D’) with the similar co-expression patterns found at 10 pcw 
(Supplementary Table 3C). Double immunostaining analysis revealed that DACH1 was then 
expressed by SST+ interneurons but not by the NR2F2+ (also known as COUPTFII) or 
CALB2+ (also known as calretinin) interneurons (Supplementary Fig. 4E-G). Our finding of 
DACH1 being strongly expressed in the human striatum is further supported by the Human 
Brain Transcriptome Atlas (Kang HJ et al. 2011) where DACH1 shows a stable expression 
until adulthood (Supplementary Fig. 5A).  
We also suggest that DACH1 is the main player in human neurodevelopmental 
processes since its paralog DACH2 is not significantly expressed both at population and 
single-cell level in the human neocortex and striatum (Supplementary Fig. 6A,B). 
 
DACH1 expression is conserved in the mouse 
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Finally, we performed a human versus mouse comparison by performing ISH and 
immunofluorescence analyses at different developmental time points in the mouse. We first 
found that at E13.5 (a stage comparable to the 10 pcw analyzed in Fig. 1) Dach1 was 
strongly expressed in the VZ/SVZ of the developing pallium (Supplementary Fig. 7A). At the 
end of the neurogenesis (E18.5), Dach1 was confined to the VZ/SVZ regions and virtually 
absent from the CP (Supplementary Fig. 7B-D). At E16.5 DACH1 showed a transitional 
expression pattern compared to E13.5 and E18.5, with high expression in the neocortical 
VZ/SVZ regions, together with PAX6, TFAP2C, and SOX3 (Supplementary Fig. 7E-G’). We 
also observed a strong expression in the striatum (Fig. 5A-H, Supplementary Fig. 7B), where 
88  ± 1.63 % of DACH1 cells co-expressed BCL11B and 82 ± 1.34 %  of the DACH1 cells 
were EBF1+ at E16.5 (Fig. 5A-D, Supplementary Table 3D). Then at P8 DACH1 marked 
MSNs together with BCL11B (94.98 ± 1.62 %) and PPP1R1B (89 ± 1.10 %) (Fig. 5D-H, 
Supplementary Table 3D).   
 
DISCUSSION 
In this study, we demonstrate that DACH1 is expressed in neuroepithelial cells and vRGCs 
of the human forebrain from the earliest stage analyzed (5 pcw) and continues to be 
expressed until mid-fetal stages (20 pcw). Moreover, we describe a peculiar DACH1 
expression in striatal MSNs, which is conserved in mouse. We show that DACH1 expression 
is temporally and spatially dynamic, suggesting multiple roles at different times and regions.  
DACH1 is expressed in neocortical neuroepithelial cells and vRGCs 
Single-cell transcriptional analysis showed that DACH1 expression significantly decreases 
between 5 and 20 pcw in proliferating neural progenitor populations in the neocortex. This 
was confirmed at protein level, as we observed a strong DACH1 signal in the embryonic 
neocortical VZ/SVZ, co-expressed with PAX6. This expression persists in the proliferative 
regions of the neocortex at least until 21 pcw, the latest developmental stage analyzed in 
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this study. Single-cell transcriptomics revealed that DACH1 is found predominately in 
neuroepithelial cells and vRGCs starting from 5 pcw, corroborating the expression in 15-18 
gestational week-old vRGCs shown by Pollen et al. (Pollen AA et al. 2015). Genes with high 
correlation with DACH1 show an enrichment in terms related to cell cycle and neural stem 
cell population maintenance, with most of the gene terms correlating to mechanisms 
involved in mitosis. Moreover, DACH1 results as a hub gene in these processes suggesting 
a potential role in regulating the cell cycle within dividing progenitors. Further strengthening 
this hypothesis is the fact that we also observed a strong DACH1 expression in the VZ of 
mice at E16.5. In line with these results, Dach1 expression is detected from E8.25 in the 
anterior neural ridge (Caubit X et al. 1999) and persists at least until P21 in the ependymal 
and sub-ependymal zones (Machon O et al. 2002). DACH1 is considered one of the markers 
of neural rosette progenitors in vitro (Elkabetz Y et al. 2008). These observations, taken 
together, advocate for DACH1 a fundamental role in neural progenitors during early stages 
of development, both in mouse and human.  
A previous study examined Dach1 mutant mice with respect to proliferation defects 
at E17.5 (Backman M et al. 2003), finding no impairments. However, they performed only a 
two-hour BrdU pulse at a single stage, thus probably missing more subtle defects that can 
be revealed by cumulative studies at different time points. DACH2 redundancy is unlikely 
because of its flat and lower expression in cerebral cortex proliferating zones 
(Supplementary Fig. 6A; Kang HJ et al. 2011). 
DACH1 has a rostro-caudal expression pattern in the human neocortex 
Neocortical parcellation is an important developmental process that gives rise to four major 
areas: the primary visual (V1), somatosensory (S1), auditory (A1) and motor (M1) areas. 
These areas are subdivisions that differ from one another by differences in cell composition, 
connections, and patterns of gene expression. The suggestion that intrinsic genetic 
mechanisms may control arealization was based on the observation of transcription factors 
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with gradients of expression along the medio-lateral and rostro-caudal axes (Sur M and JL 
Rubenstein 2005). In this study, we show that DACH1 at 10 pcw has a rostral-low to caudal-
high expression pattern of gene expression, and thus it may have a role in correct cerebral 
cortical arealization similar to the transcription factors PAX6, EMX2, COUPTFI, and SP8 
(Sur M and Rubenstein JL 2005). Alternatively, DACH1 may have a dynamic expression 
pattern in different areas at different developmental ages. 
 
A secondary site of DACH1 expression, the striatum 
A few transcription factors, for example BCL11B and SP8, are expressed both in the 
neocortex and in the basal ganglia. In particular BCL11B is expressed, both in mouse 
(Arlotta P et al. 2005; Arlotta P et al. 2008) and in human (Onorati M et al. 2014) in layer 5 
projection neurons and in the MSNs of the striatum. In this study, we report that DACH1 has 
a similar dual expression. Its striatal expression was found both in mouse tissue (E13.5, 
E16.5, and E18.5) and in human specimens (10 pcw and 21 pcw). Interestingly, this striatal 
expression was not extensively reported before even in mouse. In Davis et al. (Davis RJ et 
al. 1999) they reported a generic ganglionic eminence expression at E12.5, while Caubit et 
al. (Caubit X et al. 1999) reported an exclusive neocortical expression, even if their analysis 
was confined to the E12.5 stage. A more recent study examined Dach1 expression by ISH 
at E12.5, P0, and P21, but did not describe any expression in the striatum, except for a faint 
LGE staining (Machon O et al. 2002). We now show, using both ISH and immunostaining, 
that DACH1 is strongly expressed in the striatum in mouse and human, and that DACH1 
expression is stable until adulthood (Supplementary Fig. 5A; Kang HJ et al. 2011). 
Moreover, at 10 pcw, DACH1 was co-expressed with important mature striatal markers such 
as EBF1 (Garel S et al. 1999; Onorati M et al. 2014), ISL1 (Toresson H et al. 2000; Onorati 
M et al. 2014), BCL11B, and PPP1R1B. 
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Together, our findings suggest that DACH1 can have a dual role in the developing human 
telencephalon. The first one is in human cortical progenitors, at early developmental stages, 
as a consequence of its expression in neuroepithelial cells and vRGCs and not in cortical 
projection neurons or interneurons. Of interest, at 21 pcw it was also expressed in the LGE 
VZ, probably extending its role to other progenitor types. The second role is in the striatum, 
mostly in post-mitotic striatal MSNs where it is co-expressed with well-known MSN markers. 
DACH1 is not the only gene that acts in two different contexts within the nervous system. 
Also PAX6 and OTX2, known neural progenitor markers for the ventricular neuroepithelium 
of the developing CNS are also found in certain neuronal subpopulations in the adult brain 
(Stoykova A et al. 2000, Omodei D et al. 2008). In particular, PAX6 characterizes 
dopaminergic neurons in the glomerular layer of the olfactory bulb, granule neurons in the 
cerebellum and amacrine and ganglion cells of the retina (Stoykova A et al. 2000). Instead, 
OTX2 is expressed in a neuronal subset of ventral tegmental area (Di Salvio M et al. 2010). 
In line, the dual role of DACH1 has been described in the literature with regards to promoting 
differentiation of the Drosophila eye and limb in postmitotic cells (Mardon G et al. 1994; 
Hammond KL et al. 1998; Caubit X et al. 1999; Davis RJ et al. 1999; Kozmik Z et al. 1999) 
and in regulating proliferation and growth in cancer cells (Watanabe A et al. 2011). In 
conclusion, here, we mirror this binary action in two different areas of the telencephalon: the 
neocortex and striatum. We describe its enrichment in neocortical progenitors in 
combination with genes involved in the cell cycle, together with its typifying role in defining 
MSNs in the developing striatum.    
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CAPTIONS TO FIGURES 
Figure 1. Expression pattern of DACH1 in the human fetal cerebral cortex at 10 pcw. 
(A-C) Rostro-caudal expression pattern for DACH1 compared to KI67+ proliferative cells. 
DACH1 shows a very low expression in rostral sections (frontal cortex) (A), and a higher 
expression when moving towards the paracentral (B) and occipital cortex (C). (A’-C’) Higher 
magnification of the boxes in A-C showing the strong DACH1 expression in more caudal 
sections. DACH1 is expressed in the ventricular/subventricular zone (VZ/SVZ) where KI67+ 
proliferative cells reside. In the cortical plate (CP) there is no discernible expression. (D-F) 
High magnification of DACH1 and KI67 expression in the dorsal pallium (DP) VZ/SVZ 
(caudal level) showing that they are co-expressed in these proliferative regions. The images 
are from the DP of a section adjacent to the one shown in (B). Some DACH1+ cells are KI67-
, probably migrating neuroblasts. (G-K) DACH1 expression in the DP compared to BCL11B 
(CTIP2), a layer 5 marker. The two proteins are expressed in a complementary fashion. (H-
J) High magnification of the region highlighted in the dashed box in G, showing DACH1 
expression in the VZ/SVZ and scattered in the intermediate zone (IZ), compared to BCL11B 
expression in the CP and IZ. (K) High magnification of the region highlighted in the dashed 
box in G, showing the complementary expression pattern of DACH1 and BCL11B. Arrows 
in K point to occasional single cells co-expressing both BCL11B and DACH1.  
VP, ventral pallium; MP, medial pallium; TV, telencephalic ventricle; PSB, pallium-
subpallium boundary; TH, thalamus; STR, striatum; I.C., internal capsule.  
Scale bars: 100 μm in A-C, 50 μm in A’-F. 
 
Figure 2. Spatial-temporal expression pattern of DACH1 in the developing human cerebral 
cortex. 
(A-C) Double immunodetection of DACH1 with SOX3 (A), PAX6 (B), and KI67 (C) at 7 pcw 
+ 2d showing the co-expression of the three VZ markers with DACH1. (D-F) At 10 pcw 
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DACH1 shows a similar co-expression pattern with SOX3, PAX6, and KI67. (G,H) DACH1 
expression pattern in medio-lateral cortex at 9 pcw + 5d. The regions in the dashed box 
represent the area magnified in the boxes. DACH1 signal is localized in the VZ/SVZ, with 
no detectable signal in the CP. This pattern is conserved in more caudal sections (H). 
MZ, marginal zone; CP, cortical plate; IZ, intermediate zone; VZ/SVZ; 
ventricular/subventricular zone; PSB, pallium-subpallium boundary; CGE, caudal ganglionic 
eminence.   
Scale bars: 50 μm in A-F, 100 μm in G,H. 
 
Figure 3. Single-cell transcriptional profiling of DACH1 expression in the developing human 
neocortex.  
(A) Boxplot showing pseudotemporal ordering of cells by DACH1 expression from 5 to 20 
pcw, with a significant decrease in DACH1 expression during neocortical development. (* 
P-adj. < 0.001, one-way ANOVA with Tukey posthoc test). (B) Violin plots showing 
expression of DACH1 in different cell types of the developing neocortex. DACH1 has a 
significantly higher expression (P-adj. < 0.001, Wilcoxon test with Bonferroni correction for 
multiple comparisons) in neuroepithelial (NE) and ventricular radial glial cell (vRGCs) 
compared to the rest of the neural lineage (oRGCs, IPC, projection neurons, and 
interneurons). (C) 20 most correlated (red) and anti-correlated (blue) genes with DACH1 
(ordered by false discovery rate). (D) Hub genes within genes with high correlation with 
DACH1.  
oRGC, outer radial glial cell; IPC, intermediate progenitor cell; Proj. N., projection neurons; 
Intern., interneurons; Oligo, oligodentrocytes; Astro, astrocytes; Micro, microglia; Endo, 
endothelial cells.  
 
Figure 4. DACH1 expression in the developing human striatum. 
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(A) 10 pcw human brain coronal hemisection. The region highlighted in the dashed box 
represents the striatal area analyzed in B. (B-C’) Co-expression analysis of DACH1 and 
EBF1, a striatal marker. The region in the dashed box in B represents the area magnified in 
C-E’. (D,D’) Co-expression analysis of DACH1 with the striatal marker ISL1. (E,E’) Co-
expression analysis of DACH1 and the MSN marker BCL11B. (F) Histogram showing the 
percentage of cells co-expressing DACH1 and the indicated markers. All results are 
expressed as mean +/- s.d. (G) DACH1 co-expression with the MSN marker PPP1RB1 (see 
arrows in the inset). 
NCX, neocortex; TV, telencephalic ventricle; TH, thalamus; STR, striatum; I.C., internal 
capsule; Ca, caudate; Pu, putamen.  
Scale bars: 100 μm in A,B; 50 μm in C-E’, G. 
 
Figure 5. DACH1 expression pattern in the mouse striatum.  
(A) A representative E16.5 mouse brain coronal section. The region highlighted in the 
dashed box represents the striatal area analyzed in B,C. (B) Co-immunodetection analysis 
of DACH1 and BCL11B. (C) Co-immunodetection analysis of DACH1 and EBF1. (D) A 
representative P8 mouse coronal brain section. The region highlighted in the dashed box 
represents the striatal area analyzed in E,F. (E) Co-immunodetection analysis showing 
DACH1 and BCL11B co-expression. (F) Co-immunodetection analysis of DACH1 and 
PPP1R1B.  
NCX, neocortex; TV, telencephalic ventricle; STR, striatum; LV, lateral ventricle. 
Scale bars: 100 μm in A,D; 50 μm in B,C,E,F. 
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